Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behcet's disease

被引:15
作者
Mohammad-Ebrahim, H. [1 ,2 ,3 ]
Kamali-Sarvestani, E. [1 ,2 ]
Mahmoudi, M. [3 ]
Beigy, M. [3 ,4 ]
Karami, J. [5 ]
Ahmadzadeh, N. [3 ]
Shahram, F. [3 ]
机构
[1] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Autoimmune Dis Res Ctr, Shiraz, Iran
[3] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, SSRC, Tehran, Iran
[5] Iran Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
关键词
IRANIAN POPULATION; ANKYLOSING-SPONDYLITIS; FAMILIAL AGGREGATION; MIC-A; POLYMORPHISMS; COMBINATIONS; EXPRESSION; GENOTYPES; HLA-B51; UVEITIS;
D O I
10.1080/03009742.2017.1340510
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Behcet's disease (BD) is a systemic inflammatory disorder with remissions and exacerbations. It is thought that defects in the natural killer (NK) cell repertoire may be involved in BD through killer cell immunoglobulin-like receptors (KIRs). This study aimed to evaluate KIR and HLA genes, their interactions in BD patients, and their associations with clinical manifestations.Method: The presence or absence of KIR and HLA alleles and genotypes was analysed by polymerase chain reaction sequence-specific primer on genomic DNA of 397 BD patients and 300 healthy controls.Results: None of the KIR genes showed significant effects on BD susceptibility. HLA-C1(Asn80) showed a protective effect against BD, whereas HLA-C2(Lys80), HLA-B-Bw4(Ile80), HLA-B5, and HLA-B51 were associated with a susceptibility risk for BD. In the combination of KIR and HLA genes, the frequencies of HLA genotypes no. 2, 3, 5, and 8, and inhibitory KIR no.4 were significantly higher in patients than in controls. The frequencies of KIR genotype no.3 and HLA genotypes no.1, 4, 6, 7, and 9 were significantly lower in patients than in controls. There were many associations between KIR and HLA genes with clinical features of BD.Conclusion: Differences in the frequency of HLA genes, KIR-HLA interactions, and genotypes between BD and healthy controls and their associations with clinical manifestations indicate that NK cells are involved in BD pathogenesis. The observed differences indicated an NK cell activity imbalance in BD patients, and suggest a role of the KIR-HLA repertoire in the development of BD.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 49 条
  • [1] CD8 bright CD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis
    Ahn, JK
    Chung, H
    Lee, DS
    Yu, YS
    Yu, HG
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (09) : 6133 - 6142
  • [2] Killer Cell Immunoglobulin-like Receptor Genotypes in Behcet's Disease Patients: Any Role for the 3DP1*001/002 Pseudogene?
    Arayssi, Thourayya K.
    El Hajj, Nady
    Shamseddine, Wael
    Ibrahim, Georges
    Nasr, John
    Sabbagh, Amira S.
    Greige, Layal
    Zaatari, Ghazi S.
    Mahfouz, Rami A. R.
    [J]. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (03) : 319 - 324
  • [3] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [4] Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification
    Chainonthee, W.
    Boettcher, G.
    Gagne, K.
    Fuessel, M.
    Bignon, J. -D.
    Wassmuth, R.
    [J]. TISSUE ANTIGENS, 2010, 76 (02): : 135 - 143
  • [5] The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
    Davatchi, F.
    Assaad-Khalil, S.
    Calamia, K. T.
    Crook, J. E.
    Sadeghi-Abdollahi, B.
    Schirmer, M.
    Tzellos, T.
    Zouboulis, C. C.
    Akhlagi, M.
    Al-Dalaan, A.
    Alekberova, Z. S.
    Ali, A. A.
    Altenburg, A.
    Arromdee, E.
    Baltaci, M.
    Bastos, M.
    Benamour, S.
    Ben Ghorbel, I.
    Boyvat, A.
    Carvalho, L.
    Chen, W.
    Ben-Chetrit, E.
    Chams-Davatchi, C.
    Correia, J. A.
    Crespo, J.
    Dias, C.
    Dong, Y.
    Paixao-Duarte, F.
    Elmuntaser, K.
    Elonakov, A. V.
    Grana Gil, J.
    Haghdoost, A-A.
    Hayani, R. M.
    Houman, H.
    Isayeva, A. R.
    Jamshidi, A. R.
    Kaklamanis, P.
    Kumar, A.
    Kyrgidis, A.
    Madanat, W.
    Nadji, A.
    Namba, K.
    Ohno, S.
    Olivieri, I.
    Vaz Patto, J.
    Pipitone, N.
    de Queiroz, M. V.
    Ramos, F.
    Resende, C.
    Rosa, C. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) : 338 - 347
  • [6] Validation of the revised International Criteria for Behcet's Disease (ICBD) in Iran
    Davatchi, Fereydoun
    Abdollahi, Bahar Sadeghi
    Chams-Davatchi, Cheyda
    Shahram, Farhad
    Nadji, Abdolhadi
    Shams, Hormoz
    Faezi, Tahereh
    Akhlaghi, Massoomeh
    Ashofteh, Farimah
    Mataji, Maryam
    Moradi, Kamran
    Mohtasham, Negin
    [J]. CLINICAL RHEUMATOLOGY, 2015, 34 (02) : 315 - 320
  • [7] HLA-B51/B5 and the Risk of Behcet's Disease: A Systematic Review and Meta-Analysis of Case-Control Genetic Association Studies
    de Menthon, Mathilde
    LaValley, Michael P.
    Maldini, Carla
    Guillevin, Loic
    Mahr, Alfred
    [J]. ARTHRITIS CARE & RESEARCH, 2009, 61 (10) : 1287 - 1296
  • [8] Behet's disease: infectious aetiology, new autoantigens, and HLA-B51
    Direskeneli, H
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (11) : 996 - 1002
  • [9] EGLIN RP, 1982, LANCET, V2, P1356
  • [10] Number VII -: Behcet's disease (Adamantiades syndrome)
    Escudier, M
    Bagan, J
    Scully, C
    [J]. ORAL DISEASES, 2006, 12 (02) : 78 - 84